Award
NIH Reporter #7UG3DA062112-02
Psilocybin-Assisted Treatment of Cocaine Use Disorder
Recipient
Carilion Medical Center, Roanoke, VA, United States
Award Amount
$623,043.00
Ceiling
$623,043.00
Awarded
August 21, 2026
Identifier
7UG3DA062112-02
A research project funded by the National Institute on Drug Abuse to study psilocybin-assisted treatment for Cocaine Use Disorder, involving a randomized controlled trial to evaluate efficacy and safety.
Description
This project explores the potential efficacy and safety of psilocybin as a treatment for Cocaine Use Disorder through a proof-of-concept randomized controlled trial comparing two doses of psilocybin combined with psychedelic integrative therapy and cognitive behavioral therapy.